Tesamorelin

Specifications

INN

Tesamorelin

IUPAC / systematic name

trans-3-Hexenoyl-tyrosyl-L-alanyl-L-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-glycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-arginyl-L-glutaminyl-L-glutaminyl-glycyl-L-glutamyl-L-seryl-L-asparaginyl-L-glutaminyl-L-glutamyl-L-arginyl-glycyl-L-alanyl-L-arginyl-L-alanyl-L-arginyl-L-leucinamide

Chemical class

Modified Peptide Analog

CAS registry

218949-48-5 · PubChem

Molecular weight

5,135.9 g/mol

Amino acids

44

Form

Lyophilized powder

Structure note

N-terminal trans-3-hexenoyl modification; C-terminal amide

Quality documentation

Passing reports on record for each compound-size lot, counted once per laboratory. Purity is the lowest reported passing figure. Each batch has its own testing target; meeting it is one requirement for release.

10mg

lot EP-A1057 · purity 99.35% · 3 passing reports on record · Batch target: 3

Intended use

For in-vitro laboratory research by qualified professionals. Not for human or veterinary use of any kind — not a drug, food, cosmetic or supplement. The buyer is responsible for lawful handling, storage and disposal.

Researchers should consult the primary scientific literature for published experimental protocols and conditions relevant to their specific in-vitro or laboratory applications.